Pane in The Glass supports Arena’s new diet drug available June 8th, 2013.

Pane in The Glass trades a lot of stocks. This stock,
Arena, stock symbol arna has been around for a while. Pane in The Glass bought arna when it was in the thirties and below 2 dollars; last year. Arna is the first drup stock in 13 years to be approved by the FDA last June. Its competitor Vvus was shortly approved after Arna. However the FDA gave Vvus a quick classification and its diet pill has been on the market since last Fall. It has been a long wait for Arna but today is history! Pane in The Glass recommends buying the stock or long term calls. This stock is heavily shorted and the squeeze will double the stock by the end of the year. Get long and strong with Arna.